Tytuł artykułu

Activity of superoxide dysmutase, catalase and glutathione peroxidase in rats exposed to chlorpyrifos and erofloxacin

Tytuł czasopisma

Polish Journal of Veterinary Sciences

Rocznik

2011

Numer

No 4

Autorzy

Barski, D. ; Spodniewska, A. ; Zasadowski, A.

Wydział PAN

Nauki Biologiczne i Rolnicze

Wydawca

Polish Academy of Sciences Committee of Veterinary Sciences ; University of Warmia and Mazury in Olsztyn

Data

2011

Identyfikator

DOI: 10.2478/v10181-011-0078-8 ; ISSN 1505-1773

Źródło

Polish Journal of Veterinary Sciences; 2011; No 4

Referencje

Aebi H. (1984), Catalase <i>in vitro</i>, Methods Enzymol, 105, 121, doi.org/10.1016/S0076-6879(84)05016-3 ; Albesa I. (2004), Oxidative stress involved in the antibacterial action of different antibiotics, Biochem Biophys Res Commun, 317, 605, doi.org/10.1016/j.bbrc.2004.03.085 ; Altinordulu S. (2009), Effects of some quinolone antibiotics on malondialdehyde levels and catalase activity in chicks, Food Chem Toxicol, 47, 2821, doi.org/10.1016/j.fct.2009.08.018 ; Amitai G. (1998), Inhibition of acetylcholinesterase and butyrylcholinesterase by chlorpyrifos-oxon, Biochem Pharmacol, 56, 293, doi.org/10.1016/S0006-2952(98)00035-5 ; Anadón A. (1999), Pharmacokinetic variables and tissue residues of enrofloxacin and ciprofloxacin in healthy pigs, Am J Vet Res, 60, 1377. ; Anderson T. (2004), Synergistic and antagonistic effects of atrazine on the toxicity of organophosphorodithioate and organophosphorothioate insecticides to <i>Chironomus tentans</i> (Diptera: Chironomidae), Pestic Biochem Phys, 80, 54, doi.org/10.1016/j.pestbp.2004.06.003 ; Barski D. (2008), Activity of superoxide dismutase and catalase in erythrocytes and malondialdehyde concentration in the liver of rats exposed to Bi 58 Nowy and pyrantel, Bull Vet Inst Pulawy, 52, 299. ; Becerra M. (2004), Light effect and reactive oxygen species in the action of ciprofloxacin on <i>Staphylococcus aureus</i>, J Photochem Photobiol B, 76, 13, doi.org/10.1016/j.jphotobiol.2004.06.003 ; Benzer F. (2009), Influence of enrofloxacin administration on oxidative stress and antioxidant enzyme activities of experimentally infected broilers with <i>Salmonella enterica serovar enteritidis</i>, E-Journal of New World Sciences Academy, Veterinary Sciences, 4, 24. ; Bimazubute M. (2010), Penetration of enrofloxacin into the nasal secretions and relationship between nasal secretions and plasma enrofloxacin concentrations after intramuscular administration in healthy pigs, J Vet Pharmacol Ther, 33, 183, doi.org/10.1111/j.1365-2885.2009.01123.x ; Boothe D. (2006), Comparison of pharmacodynamic and pharmacokinetic indices of efficacy for 5 fluoroquinolones toward pathogens of dogs and cats, J Vet Intern Med, 20, 1297, doi.org/10.1111/j.1939-1676.2006.tb00742.x ; Carreras I. (2004), Influence of enrofloxacin administration and alpha-tocopheryl acetate supplemented diets on oxidative stability of broiler tissues, Poult Sci, 83, 796, doi.org/10.1093/ps/83.5.796 ; Cetin N. (2007), Chlorpyrifos induces cardiac dysfunction in rabbits, Res Vet Sci, 82, 405, doi.org/10.1016/j.rvsc.2006.08.002 ; Cochran R. (1995), Chlorpyrifos: hazard assessment based on a review of the effects of short-term and long-term exposure in animals and humans, Food Chem Toxicol, 33, 165, doi.org/10.1016/0278-6915(94)00124-7 ; J. De Lucas (2008), Pharmacokinetic behaviour of enrofloxacin in greater rheas following a single-dose intramuscular administration, Vet J, 175, 136, doi.org/10.1016/j.tvjl.2006.11.007 ; Dhalla N. (2000), Role of oxidative stress in cardiovascular diseases, J Hypertens, 18, 655, doi.org/10.1097/00004872-200018060-00002 ; Durak D. (2009), Malathion-induced oxidative stress in human erythrocytes and the protective effect of vitamins C and E in vitro, Environ Toxicol, 24, 235, doi.org/10.1002/tox.20423 ; Elmas M. (2006), Influence of Escherichia coli endotoxin-induced endotoxaemia on the pharmacokinetics of enrofloxacin after intravenous administration in rabbits, J Vet Med A Physiol Pathol Clin Med, 53, 410, doi.org/10.1111/j.1439-0442.2006.00854.x ; Foxenberg R. (2007), Human hepatic cytochrome P450-specific metabolism of parathion and chlorpyrifos, Drug Metab Dispos, 35, 189, doi.org/10.1124/dmd.106.012427 ; Goel A. (2005), Protective effects of zinc on lipid peroxidation, antioxidant enzymes and hepatic histoarchitecture in chlorpyrifos-induced toxicity, Chem Biol Interact, 156, 131, doi.org/10.1016/j.cbi.2005.08.004 ; Gotfried M. (2010), Short-course fluoroquinolones in acute exacerbations of chronic bronchitis, Expert Rev Respir Med, 4, 661, doi.org/10.1586/ers.10.52 ; Grobbel M. (2007), Comparative quantification of the in vitro activity of veterinary fluoroquinolones, Vet Microbiol, 124, 73, doi.org/10.1016/j.vetmic.2007.03.017 ; Hillier A. (2006), Pyoderma caused by <i>Pseudomonas aeruginosa</i> infection in dogs: 20 cases, Vet Dermatol, 17, 432, doi.org/10.1111/j.1365-3164.2006.00550.x ; Ihrke P. (1999), The use of fluoroquinolones in veterinary dermatology, Vet Dermatol, 10, 193, doi.org/10.1046/j.1365-3164.1999.00179.x ; B. Karademir Catalgol (2007), Effects of trichlorfon on malondialdehyde and antioxidant system in human erythrocytes, Toxicol in Vitro, 21, 1538, doi.org/10.1016/j.tiv.2007.06.002 ; Kulikowska-Karpińska E. (2004), The antioxidative barrier in the organism, Pol J Environ Stud, 13, 5. ; Lemus R. (2000), Chlorpyrifos: an unwelcome pesticide in our homes, Rev Environ Health, 15, 421, doi.org/10.1515/REVEH.2000.15.4.421 ; Lukaszewicz-Hussain A. (2008), Subchronic intoxication with chlorfenvinphos, an organophosphate insecticide, affects rat brain antioxidative enzymes and glutathione level, Food Chem Toxicol, 46, 82, doi.org/10.1016/j.fct.2007.06.038 ; Mansour S. (2009), Lipid peroxidation and oxidative stress in rat erythrocytes induced by chlorpyrifos and the protective effect of zinc, Pestic Biochem Physiol, 93, 34, doi.org/10.1016/j.pestbp.2008.09.004 ; Maroni M. (2000), Biological monitoring of pesticide exposure: a review, Toxicology, 143, 1. ; Martínez M. (2006), Pharmacology of the fluoroquinolones: a perspective for the use in domestic animals, Vet J, 172, 10, doi.org/10.1016/j.tvjl.2005.07.010 ; Muscarella D. (1984), Evaluation of the genotoxic and embryotoxic potential of chlorpyrifos and its metabolites in vivo and in vitro, Environ Mutagen, 6, 13, doi.org/10.1002/em.2860060103 ; Mutch E. (2006), Diazinon, chlorpyrifos and parathion are metabolised by multiple cytochromes P450 in human liver, Toxicology, 224, 22, doi.org/10.1016/j.tox.2006.04.024 ; Pitchumoni S. (1998), Current status of antioxidant therapy for Alzheimer's Disease, J Am Geriatr Soc, 46, 1566, doi.org/10.1111/j.1532-5415.1998.tb01544.x ; Riddle C. (2000), Evaluation of ciprofloxacin as a representative of veterinary fluoroquinolones in susceptibility testing, J Clin Microbiol, 38, 1636. ; Sams C. (2004), Biotransformation of chlorpyrifos and diazinon by human liver microsomes and recombinant human cytochrome P450s (CYP), Xenobiotica, 34, 861, doi.org/10.1080/00498250400017273 ; Shenouda J. (2009), An evaluation of the inhibition of human butyrylcholinesterase and acetylcholinesterase by the organophosphate chlorpyrifos oxon, Toxicol Appl Pharmacol, 241, 135, doi.org/10.1016/j.taap.2009.08.014 ; Sivapiriya V. (2006), Effects of dimethoate (<i>O, O</i>-dimethyl <i>S</i>-methyl carbamoyl methyl phosphorodithioate) and ethanol in antioxidant status of liver and kidney of experimental mice, Pestic Biochem Phys, 85, 115, doi.org/10.1016/j.pestbp.2005.12.001 ; Sultatos L. (1983), Hepatic microsomal detoxification of the organophosphates paraoxon and chlorpyrifos oxon in the mouse, Drug Metab Dispos, 11, 232. ; Traş B. (2001), Investigation of biochemical and haematological side-effects of enrofloxacin in dogs, J Vet Med A Physiol Pathol Clin Med, 48, 59, doi.org/10.1046/j.1439-0442.2001.00332.x ; Tu H. (2008), Oxidative stress response of black tiger shrimp (<i>Penaeus monodon</i>) to enrofloxacin and to culture system, Aquaculture, 285, 244, doi.org/10.1016/j.aquaculture.2008.08.032 ; Uzun F. (2010), Protective effect of catechin and quercetin on chlorpyrifos-induced lung toxicity in male rats, Food Chem Toxicol, 48, 1714, doi.org/10.1016/j.fct.2010.03.051 ; Vancutsem P. (1990), The fluoroquinolone antimicrobials: structure, antimicrobial activity, pharmacokinetics, clinical use in domestic animals and toxicity, Cornell Vet, 80, 173. ; Verma R. (2007), In vivo chlorpyrifos induced oxidative stress: Attenuation by antioxidant vitamins, Pestic Biochem Phys, 88, 191, doi.org/10.1016/j.pestbp.2006.11.002 ; Wang Y. (2010), Molecular characterization of enrofloxacin resistant <i>Actinobacillus pleuropneumoniae</i> isolates, Vet Microbiol, 142, 309, doi.org/10.1016/j.vetmic.2009.09.067 ; Wiuff C. (2002), Distribution of enrofloxacin in intestinal tissue and contents of healthy pigs after oral and intramuscular administrations, J Vet Pharmacol Ther, 25, 335, doi.org/10.1046/j.1365-2885.2002.00430.x ; Yazar E. (2001), Effects of fluoroquinolone antibiotics on hepatic superoxide dismutase and glutathione peroxidase activities in healthy and experimentally induced peritonitis mice, Revue Med Vet, 152, 235. ; Zhang L. (2011), Effects of fluoroquinolones on CYP4501A and 3A in male broilers, Res Vet Sci, 90, 99, doi.org/10.1016/j.rvsc.2010.04.025